BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21239074)

  • 1. Late microvascular obstruction after acute myocardial infarction: relation with cardiac and inflammatory markers.
    Mayr A; Klug G; Schocke M; Trieb T; Mair J; Pedarnig K; Pachinger O; Jaschke W; Metzler B
    Int J Cardiol; 2012 Jun; 157(3):391-6. PubMed ID: 21239074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac magnetic resonance imaging study for quantification of infarct size comparing directly serial versus single time-point measurements of cardiac troponin T.
    Giannitsis E; Steen H; Kurz K; Ivandic B; Simon AC; Futterer S; Schild C; Isfort P; Jaffe AS; Katus HA
    J Am Coll Cardiol; 2008 Jan; 51(3):307-14. PubMed ID: 18206741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Blush Evaluator accurately quantifies microvascular dysfunction in patients with ST-elevation myocardial infarction: comparison with cardiovascular magnetic resonance.
    Porto I; Hamilton-Craig C; De Maria GL; Vergallo R; Cautilli G; Galiuto L; Burzotta F; Leone AM; Niccoli G; Natale L; Bonomo L; Crea F
    Am Heart J; 2011 Aug; 162(2):372-381.e2. PubMed ID: 21835300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction.
    Steen H; Futterer S; Merten C; Jünger C; Katus HA; Giannitsis E
    J Cardiovasc Magn Reson; 2007; 9(5):749-58. PubMed ID: 17891611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimarker approach for the prediction of microvascular obstruction after acute ST-segment elevation myocardial infarction: a prospective, observational study.
    Feistritzer HJ; Reinstadler SJ; Klug G; Reindl M; Wöhrer S; Brenner C; Mayr A; Mair J; Metzler B
    BMC Cardiovasc Disord; 2016 Nov; 16(1):239. PubMed ID: 27894261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of biomarker strategies for rapid rule out of myocardial infarction in the emergency department using ACC/ESC diagnostic criteria.
    Collinson PO; Gaze DC; Morris F; Morris B; Price A; Goodacre S
    Ann Clin Biochem; 2006 Jul; 43(Pt 4):273-80. PubMed ID: 16824277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-sensitivity troponin T for prediction of left ventricular function and infarct size one year following ST-elevation myocardial infarction.
    Reinstadler SJ; Feistritzer HJ; Klug G; Mair J; Tu AM; Kofler M; Henninger B; Franz WM; Metzler B
    Int J Cardiol; 2016 Jan; 202():188-93. PubMed ID: 26397408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-sensitivity cardiac troponin in the distinction of acute myocardial infarction from acute cardiac noncoronary artery disease.
    Haaf P; Drexler B; Reichlin T; Twerenbold R; Reiter M; Meissner J; Schaub N; Stelzig C; Freese M; Heinzelmann A; Meune C; Balmelli C; Freidank H; Winkler K; Denhaerynck K; Hochholzer W; Osswald S; Mueller C
    Circulation; 2012 Jul; 126(1):31-40. PubMed ID: 22623715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late gadolinium-enhanced cardiovascular magnetic resonance evaluation of infarct size and microvascular obstruction in optimally treated patients after acute myocardial infarction.
    Nijveldt R; Beek AM; Hofman MB; Umans VA; Algra PR; Spreeuwenberg MD; Visser CA; van Rossum AC
    J Cardiovasc Magn Reson; 2007; 9(5):765-70. PubMed ID: 17891613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of cardiac troponin-I compared to creatine kinase-myocardial band for the assessment of infarct size as measured by cardiac magnetic resonance.
    Di Chiara A; Dall'Armellina E; Badano LP; Meduri S; Pezzutto N; Fioretti PM
    J Cardiovasc Med (Hagerstown); 2010 Aug; 11(8):587-92. PubMed ID: 20588136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence and extent of cardiac magnetic resonance microvascular obstruction in reperfused non-ST-elevated myocardial infarction and correlation with infarct size and myocardial enzyme release.
    Mewton N; Bonnefoy E; Revel D; Ovize M; Kirkorian G; Croisille P
    Cardiology; 2009; 113(1):50-8. PubMed ID: 18984954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Troponin-I concentration 72 h after myocardial infarction correlates with infarct size and presence of microvascular obstruction.
    Younger JF; Plein S; Barth J; Ridgway JP; Ball SG; Greenwood JP
    Heart; 2007 Dec; 93(12):1547-51. PubMed ID: 17540686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting microvascular obstruction with cardiac troponin T after acute myocardial infarction: a correlative study with contrast-enhanced magnetic resonance imaging.
    Neizel M; Futterer S; Steen H; Giannitsis E; Reinhardt L; Lossnitzer D; Lehrke S; Jaffe AS; Katus HA
    Clin Res Cardiol; 2009 Sep; 98(9):555-62. PubMed ID: 19582365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microvascular obstruction assessed by 3-tesla magnetic resonance imaging in acute myocardial infarction is correlated with plasma troponin I levels.
    Pernet K; Ecarnot F; Chopard R; Seronde MF; Plastaras P; Schiele F; Meneveau N
    BMC Cardiovasc Disord; 2014 Apr; 14():57. PubMed ID: 24886208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Midregional pro-A-type natriuretic peptide for diagnosis and prognosis in patients with suspected acute myocardial infarction.
    Meune C; Twerenbold R; Drexler B; Balmelli C; Wolf C; Haaf P; Reichlin T; Irfan A; Reiter M; Zellweger C; Meissner J; Stelzig C; Freese M; Capodarve I; Mueller C
    Am J Cardiol; 2012 Apr; 109(8):1117-23. PubMed ID: 22257708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMGB1 as a predictor of infarct transmurality and functional recovery in patients with myocardial infarction.
    Andrassy M; Volz HC; Riedle N; Gitsioudis G; Seidel C; Laohachewin D; Zankl AR; Kaya Z; Bierhaus A; Giannitsis E; Katus HA; Korosoglou G
    J Intern Med; 2011 Sep; 270(3):245-53. PubMed ID: 21362071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention.
    Hassan AK; Bergheanu SC; Hasan-Ali H; Liem SS; van der Laarse A; Wolterbeek R; Atsma DE; Schalij MJ; Jukema JW
    Am J Cardiol; 2009 Mar; 103(6):779-84. PubMed ID: 19268731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart fatty acid-binding protein in combination with the 80-lead body surface potential map improves early detection of acute myocardial infarction in patients who are cardiac troponin T-negative at presentation.
    Daly MJ; McCann CJ; Owens CG; Harbinson MT; Adgey JA
    J Electrocardiol; 2011; 44(4):432-8. PubMed ID: 21529821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The size does not matter - the presence of microvascular obstruction but not its extent corresponds to larger infarct size in reperfused STEMI.
    Małek ŁA; Śpiewak M; Kłopotowski M; Miśko J; Rużyłło W; Witkowski A
    Eur J Radiol; 2012 Oct; 81(10):2839-43. PubMed ID: 22197092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cardiac troponin I versus T and creatine kinase MB after coronary artery bypass grafting in patients with and without perioperative myocardial infarction.
    Peivandi AA; Dahm M; Opfermann UT; Peetz D; Doerr F; Loos A; Oelert H
    Herz; 2004 Nov; 29(7):658-64. PubMed ID: 15580320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.